319 related articles for article (PubMed ID: 24973761)
1. Protection against Rift Valley fever virus infection in mice upon administration of interferon-inducing RNA transcripts from the FMDV genome.
Lorenzo G; Rodríguez-Pulido M; López-Gil E; Sobrino F; Borrego B; Sáiz M; Brun A
Antiviral Res; 2014 Sep; 109():64-7. PubMed ID: 24973761
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus.
Näslund J; Lagerqvist N; Habjan M; Lundkvist A; Evander M; Ahlm C; Weber F; Bucht G
Virology; 2009 Mar; 385(2):409-15. PubMed ID: 19157482
[TBL] [Abstract][Full Text] [Related]
3. Inoculation of newborn mice with non-coding regions of foot-and-mouth disease virus RNA can induce a rapid, solid and wide-range protection against viral infection.
Rodríguez-Pulido M; Sobrino F; Borrego B; Sáiz M
Antiviral Res; 2011 Dec; 92(3):500-4. PubMed ID: 22020303
[TBL] [Abstract][Full Text] [Related]
4. A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.
Boshra H; Lorenzo G; Rodriguez F; Brun A
Vaccine; 2011 Jun; 29(27):4469-75. PubMed ID: 21549790
[TBL] [Abstract][Full Text] [Related]
5. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
Terasaki K; Tercero BR; Makino S
Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
[TBL] [Abstract][Full Text] [Related]
6. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
[TBL] [Abstract][Full Text] [Related]
7. Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
Busquets N; Lorenzo G; López-Gil E; Rivas R; Solanes D; Galindo-Cardiel I; Abad FX; Rodríguez F; Bensaid A; Warimwe G; Gilbert SC; Domingo M; Brun A
Antiviral Res; 2014 Aug; 108():165-72. PubMed ID: 24933081
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
[TBL] [Abstract][Full Text] [Related]
9. Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
Wichgers Schreur PJ; Kant J; van Keulen L; Moormann RJ; Kortekaas J
Vaccine; 2015 Mar; 33(12):1459-64. PubMed ID: 25665959
[TBL] [Abstract][Full Text] [Related]
10. Genetically Modified Rabies Virus Vector-Based Rift Valley Fever Virus Vaccine is Safe and Induces Efficacious Immune Responses in Mice.
Zhang S; Hao M; Feng N; Jin H; Yan F; Chi H; Wang H; Han Q; Wang J; Wong G; Liu B; Wu J; Bi Y; Wang T; Sun W; Gao Y; Yang S; Zhao Y; Xia X
Viruses; 2019 Oct; 11(10):. PubMed ID: 31597372
[TBL] [Abstract][Full Text] [Related]
11. Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in mice.
Borrego B; Rodríguez-Pulido M; Mateos F; de la Losa N; Sobrino F; Sáiz M
Vaccine; 2013 Sep; 31(40):4375-81. PubMed ID: 23859841
[TBL] [Abstract][Full Text] [Related]
12. Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever.
Wallace DB; Ellis CE; Espach A; Smith SJ; Greyling RR; Viljoen GJ
Vaccine; 2006 Nov; 24(49-50):7181-9. PubMed ID: 16870311
[TBL] [Abstract][Full Text] [Related]
13. Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
Wichgers Schreur PJ; van Keulen L; Kant J; Kortekaas J
Vaccine; 2017 May; 35(23):3123-3128. PubMed ID: 28457675
[TBL] [Abstract][Full Text] [Related]
14. Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge.
de Boer SM; Kortekaas J; Antonis AF; Kant J; van Oploo JL; Rottier PJ; Moormann RJ; Bosch BJ
Vaccine; 2010 Mar; 28(11):2330-9. PubMed ID: 20056185
[TBL] [Abstract][Full Text] [Related]
15. Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector.
Kortekaas J; de Boer SM; Kant J; Vloet RP; Antonis AF; Moormann RJ
Vaccine; 2010 Jun; 28(27):4394-401. PubMed ID: 20434545
[TBL] [Abstract][Full Text] [Related]
16. Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge.
Gowen BB; Bailey KW; Scharton D; Vest Z; Westover JB; Skirpstunas R; Ikegami T
Antiviral Res; 2013 May; 98(2):135-43. PubMed ID: 23523764
[TBL] [Abstract][Full Text] [Related]
17. A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.
López-Gil E; Lorenzo G; Hevia E; Borrego B; Eiden M; Groschup M; Gilbert SC; Brun A
PLoS Negl Trop Dis; 2013; 7(7):e2309. PubMed ID: 23875044
[TBL] [Abstract][Full Text] [Related]
18. Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge.
Dodd KA; Bird BH; Metcalfe MG; Nichol ST; Albariño CG
J Virol; 2012 Apr; 86(8):4204-12. PubMed ID: 22345465
[TBL] [Abstract][Full Text] [Related]
19. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1110-4. PubMed ID: 9328663
[TBL] [Abstract][Full Text] [Related]
20. RNA immunization can protect mice against foot-and-mouth disease virus.
Pulido MR; Sobrino F; Borrego B; Sáiz M
Antiviral Res; 2010 Mar; 85(3):556-8. PubMed ID: 20005905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]